BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 21889345)

  • 1. Synthesis, biological evaluation and molecular docking studies of 1,3,4-thiadiazole derivatives containing 1,4-benzodioxan as potential antitumor agents.
    Sun J; Yang YS; Li W; Zhang YB; Wang XL; Tang JF; Zhu HL
    Bioorg Med Chem Lett; 2011 Oct; 21(20):6116-21. PubMed ID: 21889345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, biological evaluation, and molecular docking studies of novel 2-styryl-5-nitroimidazole derivatives containing 1,4-benzodioxan moiety as FAK inhibitors with anticancer activity.
    Duan YT; Yao YF; Huang W; Makawana JA; Teraiya SB; Thumar NJ; Tang DJ; Tao XX; Wang ZC; Jiang AQ; Zhu HL
    Bioorg Med Chem; 2014 Jun; 22(11):2947-54. PubMed ID: 24792811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antitumor activity of 1,2,4-triazoles having 1,4-benzodioxan fragment as a novel class of potent methionine aminopeptidase type II inhibitors.
    Hou YP; Sun J; Pang ZH; Lv PC; Li DD; Yan L; Zhang HJ; Zheng EX; Zhao J; Zhu HL
    Bioorg Med Chem; 2011 Oct; 19(20):5948-54. PubMed ID: 21925884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, biological evaluation, and molecular docking studies of 1,3,4-thiadiazol-2-amide derivatives as novel anticancer agents.
    Yang XH; Xiang L; Li X; Zhao TT; Zhang H; Zhou WP; Wang XM; Gong HB; Zhu HL
    Bioorg Med Chem; 2012 May; 20(9):2789-95. PubMed ID: 22503364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, biological evaluation, and molecular docking studies of 1,3,4-oxadiazole derivatives possessing 1,4-benzodioxan moiety as potential anticancer agents.
    Zhang XM; Qiu M; Sun J; Zhang YB; Yang YS; Wang XL; Tang JF; Zhu HL
    Bioorg Med Chem; 2011 Nov; 19(21):6518-24. PubMed ID: 21962523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of a series of 1,3,4-oxadiazole-2(3H)-thione derivatives containing piperazine skeleton as potential FAK inhibitors.
    Sun J; Ren SZ; Lu XY; Li JJ; Shen FQ; Xu C; Zhu HL
    Bioorg Med Chem; 2017 May; 25(9):2593-2600. PubMed ID: 28363444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and antiproliferative activity of some new thieno[2,3-d]pyrimidin-4(3H)-ones containing 1,2,4-triazole and 1,3,4-thiadiazole moiety.
    Mavrova ATs; Wesselinova D; Tsenov JA; Lubenov LA
    Eur J Med Chem; 2014 Oct; 86():676-83. PubMed ID: 25222878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antitumor-evaluation of 1,3-selenazole-containing 1,3,4-thiadiazole derivatives.
    Zhao HC; Shi YP; Liu YM; Li CW; Xuan LN; Wang P; Zhang K; Chen BQ
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6577-9. PubMed ID: 24239016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and biological evaluation of heterocyclic azoles derivatives containing pyrazine moiety as potential telomerase inhibitors.
    Zhang YB; Wang XL; Liu W; Yang YS; Tang JF; Zhu HL
    Bioorg Med Chem; 2012 Nov; 20(21):6356-65. PubMed ID: 23018096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and Molecular Docking of Some Novel Thiazoles and Thiadiazoles Incorporating Pyranochromene Moiety as Potent Anticancer Agents.
    Gomha SM; Abdelhamid AO; Kandil OM; Kandeel SM; Abdelrehem NA
    Mini Rev Med Chem; 2018; 18(19):1670-1682. PubMed ID: 29692239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel diosgenin derivatives containing 1,3,4-oxadiazole/thiadiazole moieties as potential antitumor agents: Design, synthesis and cytotoxic evaluation.
    Zhang J; Wang X; Yang J; Guo L; Wang X; Song B; Dong W; Wang W
    Eur J Med Chem; 2020 Jan; 186():111897. PubMed ID: 31761382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, biological evaluation, and molecular docking studies of novel 1,3,4-oxadiazole derivatives possessing benzotriazole moiety as FAK inhibitors with anticancer activity.
    Zhang S; Luo Y; He LQ; Liu ZJ; Jiang AQ; Yang YH; Zhu HL
    Bioorg Med Chem; 2013 Jul; 21(13):3723-9. PubMed ID: 23673215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, biological evaluation, and molecular docking studies of cinnamic acyl 1,3,4-thiadiazole amide derivatives as novel antitubulin agents.
    Yang XH; Wen Q; Zhao TT; Sun J; Li X; Xing M; Lu X; Zhu HL
    Bioorg Med Chem; 2012 Feb; 20(3):1181-7. PubMed ID: 22261027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and Evaluation of a Series of 1,3,4-Thiadiazole Derivatives as Potential Anticancer Agents.
    Altıntop MD; Sever B; Özdemir A; Ilgın S; Atlı Ö; Turan-Zitouni G; Kaplancıklı ZA
    Anticancer Agents Med Chem; 2018; 18(11):1606-1616. PubMed ID: 29745341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and Anticancer Activity of Thiadiazole Containing Thiourea, Benzothiazole and Imidazo[2,1-b][1,3,4]thiadiazole Scaffolds.
    Avvaru SP; Noolvi MN; More UA; Chakraborty S; Dash A; Aminabhavi TM; Narayan KP; Sutariya V
    Med Chem; 2021; 17(7):750-765. PubMed ID: 32427086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antiproliferative studies of 5-aryl-2-(3-thienylamino)-1,3,4-thiadiazoles.
    Revelant G; Gadais C; Mathieu V; Kirsch G; Hesse S
    Bioorg Med Chem Lett; 2014 Jun; 24(12):2724-7. PubMed ID: 24815511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel benzotriazole N-acylarylhydrazone hybrids: Design, synthesis, anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis and FAK inhibition.
    Kassab AE; Hassan RA
    Bioorg Chem; 2018 Oct; 80():531-544. PubMed ID: 30014921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antiproliferative activity of imidazo[2,1-b][1,3,4]thiadiazole derivatives.
    Kumar S; Gopalakrishnan V; Hegde M; Rana V; Dhepe SS; Ramareddy SA; Leoni A; Locatelli A; Morigi R; Rambaldi M; Srivastava M; Raghavan SC; Karki SS
    Bioorg Med Chem Lett; 2014 Oct; 24(19):4682-4688. PubMed ID: 25205189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, Molecular Docking Screening and Anti-Proliferative Potency Evaluation of Some New Imidazo[2,1-
    Rashdan HRM; Abdelmonsef AH; Shehadi IA; Gomha SM; Soliman AMM; Mahmoud HK
    Molecules; 2020 Oct; 25(21):. PubMed ID: 33126630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and evaluation of 4-substituted anthra[2,1-c][1,2,5]thiadiazole-6,11-dione derivatives as novel non-camptothecin topoisomerase I inhibitors.
    Dong G; Fang Y; Liu Y; Liu N; Wu S; Zhang W; Sheng C
    Bioorg Med Chem Lett; 2017 May; 27(9):1929-1933. PubMed ID: 28351590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.